BeOne Medicines
ONC
#817
Rank
HK$242.18 B
Marketcap
HK$2,334
Share price
2.38%
Change (1 day)
21.75%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Financial Statements

Thumbnail BeOne Medicines Financial Statement 2025

Financial Statement 2025

Language: English

View Financial Statement